Quickplay Joins AWS ISV Accelerate Program
Quickplay's full solutions portfolio is available in the
"Since partnering with AWS, our collective team has made swift and impactful progress around the world - from
The AWS ISV Accelerate Program provides Quickplay with co-sell support and benefits to meet customer needs through collaboration with AWS field sellers globally. Co-selling provides better customer outcomes and assures mutual commitment from AWS and its partners.
AWS ISV Accelerate Program members are held to the industry's highest standards and must undergo a comprehensive evaluation to gain acceptance into the program. Quickplay participated in a thorough architectural and security review to ensure the quality and design of our solutions. Proof of customer excellence was also reviewed to validate the successes Quickplay customers have achieved across industry verticals.
Quickplay's solutions are available worldwide. To learn more, visit https://quickplay.com/ or visit the Quickplay AWS marketplace listing.
For more information about Quickplay's portfolio or to schedule a demo at IBC 2025, please email [email protected].
About Quickplay
Quickplay is leading cloud transformations of OTT and in-home experiences for pay-TV, telcos, and MVPDs. The company's cloud-native platform leverages a transformative open architecture for unparalleled performance in delivering premium video, handling complex use cases, and scaling to millions of viewers. Founded by a team that has built and operated dozens of Tier 1 OTT services worldwide, Quickplay is powering immersive sports, live experiences and personalized entertainment on any screen. The company is headquartered in
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/quickplay-joins-aws-isv-accelerate-program-302552924.html
SOURCE Quickplay
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Labor and Employment Firm Zakay Law Group APLC Files A Class Action Lawsuit Against Abode Services Alleging Failure to Pay All Wages Due
- Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque P
- Toncoin Price Prediction: TON Buyers Search for the Next Catalyst as Remittix Opens Early Platform Access
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share